Augmented cAMP Signaling by Co-Administration of Resveratrol and Curcumin: A Cellular Biosensor Kinetic Assessment
Background: Curcumin and resveratrol are two polyphenolic compounds extensively investigated for their medicinal effects on inflammatory signaling. However, there is a paucity of information on the Adenosine-3’, 5’-cyclic monophosphate (cAMP) kinetics following administration of curcumin and resveratrol in biological systems. In this study, kinetic modulation of cAMP as a target detection messenger in pro-inflammatory pathways was assessed by co-administration of curcumin and resveratrol using a cellular sensor model.
Methods: To evaluate their putative activity, curcumin and resveratrol compounds were administered alone or in combination on the media culture of cAMP EPAC (exchange protein directly activated by cAMP) bioluminescence resonance energy transfer (BRET) biosensor. The study was performed at the following two centers at Tehran University of Medical Sciences (TUMS): 1- Biotechnology Research Center, and, 2- Endocrinology and Metabolism Research Institute (EMRI) in 2017. Time course kinetic of cAMP response signals were plotted. Forskolin and IBMX were used to stabilize the cAMP signals.
Results: When we treated HEK-293T biosensor cells at 10uM concentration, curcumin and resveratrol upregulated cAMP signaling. Co-administration of resveratrol and curcumin revealed an augmented cAMP level, as compared to treatments with the compounds alone.
Conclusion: Co-administration of curcumin and resveratrol leverage cAMP kinetic response in a time-course manner. The presented methodology can be readily adopted for drug development and novel biopharmaceutical functional analyses.
2. Faas MM, Sáez T, de Vos P (2017). Extracel-lular ATP and adenosine: The Yin and Yangin immune responses? Mol Aspects Med, 55:9-19.
3. Shu J, Zhang F, Zhang L, et al (2017). G protein coupled receptors signaling pathways implicate in inflammatory and immune response of rheumatoid arthritis. Inflamm Res,66(5):379-387.
4. Mirzaei H, Shakeri A, Rashidi B, et al (2017). Phytosomal curcumin: A review of pharmacokinetic, experimental and clini-cal studies. Biomed Pharmacother, 85:102-112.
5. Kunnumakkara AB, Bordoloi D, Padmava-thi G, et al (2017). Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol, 174(11):1325-1348.
6. El-Azab MF, Attia FM, El-Mowafy AM (2011). Novel role of curcumin combined with bone marrow transplantation in re-versing experimental diabetes: Effects on pancreatic islet regeneration, oxidative stress, and inflammatory cytokines. Eur J Pharmacol, 658(1):41-8.
7. Thota RN, Acharya SH, Abbott KA, et al (2016). Curcumin and long-chain Ome-ga-3 polyunsaturated fatty acids for Pre-vention of type 2 Diabetes (COP-D): study protocol for a randomised con-trolled trial. Trials, 17(1):565.
8. Diaz-Gerevini GT, Repossi G, Dain A, et al (2016). Beneficial action of resveratrol: How and why? Nutrition, 32 (2): 174-8.
9. El-Mowafy AM, Alkhalaf M (2003). Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estro-gen receptor-independent cytostatic mechanism. Carcinogenesis, 24(5): 869-73.
10. El-Mowafy AM (2002). Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: a novel signaling mechanism in support of coro-nary protection. Biochem Biophys Res Com-mun, 291(5): 1218-24.
11. Beaudeux JL, Nivet-Antoine V, Giral P (2010). Resveratrol: a relevant pharmaco-logical approach for the treatment of metabolic syndrome? Curr Opin Clin Nutr Metab Care, 13(6): 729-36.
12. Kamaleddin MA (2016). The paradoxical pro- and antiangiogenic actions of resveratrol: therapeutic applications in cancer and diabetes. Ann N Y Acad Sci, 1386(1): 3-15.
13. Szkudelska K, Nogowski L, Szkudelski T (2011). Resveratrol and genistein as adenosine triphosphate-depleting agents in fat cells. Metabolism, 60(5): 720-9.
14. Fiori JL, Shin YK, Kim W, et al (2013). Resveratrol prevents β-cell dedifferentia-tion in nonhuman primates given a high-fat/high-sugar diet. Diabetes, 62 (10): 3500-13.
15. Kar P, Laight D, Rooprai HK, et al (2009). Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, ox-idative stress and insulin sensitivity. Diabet Med, 26 (5):526-31.
16. Brasnyó P, Molnár GA, Mohás M, et al (2011). Resveratrol improves insulin sen-sitivity, reduces oxidative stress and acti-vates the Akt pathway in type 2 diabetic patients. Br J Nutr, 106 (3): 383-9.
17. Bhatt JK, Thomas S, Nanjan MJ (2012). Resveratrol supplementation improves glycemic control in type 2 diabetes melli-tus. Nutr Res, 32 (7):537-41.
18. Hausenblas HA, Schoulda JA, Smoliga JM (2015). Resveratrol treatment as an ad-junct to pharmacological management in type 2 diabetes mellitus--systematic review and meta-analysis. Mol Nutr Food Res, 59 (1): 147-59.
19. Barak LS, Salahpour A, Zhang X, et al (2008). Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Mol Pharmacol, 74(3): 585-94.
20. Kobayashi H, Picard LP, Schönegge AM, et al (2019). Bioluminescence resonance en-ergy transfer-based imaging of protein-protein interactions in living cells. Nat Protoc, 14(4):1084-1107.
21. Wimmer T, Schroeter E, Lorenz B, et al (2017). Detection of the Vascular Endo-thelial Growth Factor with a Novel Bio-luminescence Resonance Energy Transfer Pair Using a Two-Component System. Sensors (Basel), 17(1):E145.
22. Violin JD, DiPilato LM, Yildirim N, et al (2008). Beta2-adrenergic receptor signal-ing and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J Biol Chem, 283(5): 2949-61.
23. Tengholm A (2012). Cyclic AMP dynamics in the pancreatic b-cell. Ups J Med Sci, 117(4):355-69.
24. DiPilato LM, Cheng X, Zhang J (2004). Fluorescent indicators of cAMP and Epac activation reveal differential dynam-ics of cAMP signaling within discrete subcellular compartments. Proc Natl Acad Sci U S A, 101(47): 16513-8.
25. Zingg JM, Hasan ST, Nakagawa K, et al (2017). Modulation of cAMP levels by high-fat diet, curcumin, and regulatory ef-fects on CD36/FAT scavenger recep-tor/fatty acids transporter gene expres-sion. Biofactors, 43(1):42-53.
26. Ray Hamidie RD, Yamada T, Ishizawa R, et al (2015). Curcumin treatment enhances the effect of exercise on mitochondrial biogenesis in skeletal muscle by increas-ing cAMP levels. Metabolism, 64(10): 1334-47.
27. Bruckbauer A, Zemel MB, Thorpe T, et al (2012). Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond), 9(1):77.
28. Xu S, Gao Y, Zhang Q, et al (2016). SIRT1/3 Activation by Resveratrol At-tenuates Acute Kidney Injury in a Septic Rat Model. Oxid Med Cell Longev, 2016:7296092.
29. Thiel G, Rössler OG (2016). Resveratrol stimulates cyclic AMP response element mediated gene transcription. Mol Nutr Food Res, 60 (2): 256-65.
|Issue||Vol 48 No 7 (2019)|
|cAMP Cellular biosensor Curcumin Inflammation Resveratrol|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|